Juan Jesús
Cruz Hernández
![Foto de Juan Jesús](/img/uploaded/6bc762c494c7f3c45062d2723e4f76f3.jpg)
![Foto de University Medical Center Hamburg-Eppendorf](/img/noimage_org.png)
University Medical Center Hamburg-Eppendorf
Hamburgo, AlemaniaPublications en collaboration avec des chercheurs de University Medical Center Hamburg-Eppendorf (1)
2021
-
Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial
The Lancet Oncology, Vol. 22, Núm. 4, pp. 463-475